Mark Lansdown
Mark Lansdown
Unknown affiliation
Verified email at leedsth.nhs.uk
Title
Cited by
Cited by
Year
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen
J Adams, PJ Carder, S Downey, MA Forbes, K MacLennan, V Allgar, ...
Cancer research 60 (11), 2898-2905, 2000
4882000
Breast cancer cell lines: friend or foe?
SE Burdall, AM Hanby, MRJ Lansdown, V Speirs
Breast cancer research 5 (2), 1-7, 2003
4092003
Gastric cancer: a curable disease in Britain.
HM Sue-Ling, D Johnston, IG Martin, MF Dixon, MR Lansdown, ...
British Medical Journal 307 (6904), 591-596, 1993
3091993
Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model
GP Skliris, K Munot, SM Bell, PJ Carder, S Lane, K Horgan, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
2602003
Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism
CN Patel, HM Salahudeen, M Lansdown, AF Scarsbrook
Clinical radiology 65 (4), 278-287, 2010
1992010
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma.
M Lansdown, P Quirke, MF Dixon, AT Axon, D Johnston
Gut 31 (9), 977-983, 1990
1941990
Oestrogen receptor β: what it means for patients with breast cancer
V Speirs, PJ Carder, S Lane, D Dodwell, MRJ Lansdown, AM Hanby
The lancet oncology 5 (3), 174-181, 2004
1722004
Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations
RE Coleman, WW Bolten, M Lansdown, S Dale, C Jackisch, D Merkel, ...
Cancer treatment reviews 34 (3), 275-282, 2008
1382008
Immunohistochemical detection of ERβ in breast cancer: towards more detailed receptor profiling?
GP Skliris, PJ Carder, MRJ Lansdown, V Speirs
British journal of cancer 84 (8), 1095-1098, 2001
1132001
Sentinel lymph node biopsy in male breast cancer patients
A Goyal, K Horgan, M Kissin, C Yiangou, M Sibbering, M Lansdown, ...
European Journal of Surgical Oncology (EJSO) 30 (5), 480-483, 2004
932004
Teaching laparoscopic surgery: the need for guidelines
CMS Royston, MRJ Lansdown, WA Brough
Bmj 308 (6935), 1023-1025, 1994
841994
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
S Potter, EJ Conroy, RI Cutress, PR Williamson, L Whisker, S Thrush, ...
The Lancet Oncology 20 (2), 254-266, 2019
812019
Culture, attitude and knowledge about breast cancer and preventive measures: a qualitative study of South Asian breast cancer patients in the UK
G Karbani, JN Lim, J Hewison, K Atkin, K Horgan, M Lansdown, CE Chu
Asian Pac J Cancer Prev 12 (6), 1619-26, 2011
792011
Steroid hormone receptor expression in male breast cancer
CE Murphy, PJ Carder, MRJ Lansdown, V Speirs
European Journal of Surgical Oncology (EJSO) 32 (1), 44-47, 2006
782006
The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment
S Duffy, TL Jackson, M Lansdown, K Philips, M Wells, S Pollard, G Clack, ...
Human reproduction 21 (2), 545-553, 2006
772006
Who Operates When? II; the 2003 Report of the National Confidential Enquiry Into Perioperative Deaths
National Confidential Enquiry into Perioperative Deaths 2003, ...
NCEPOD, 2003
752003
Helicobacter gastritis and intestinal metaplasia in a gastric cancer family
N Scott, R Diament, V Murday, M McMahon, M Lansdown, B Rathbone, ...
The Lancet 335 (8691), 728, 1990
721990
For Better, for Worse?: A Review of the Care of Patients who Died Within 30 Days of Receiving Systemic Anti-cancer Therapy: a Report by the National Confidential Enquiry Into …
National Confidential Enquiry into Patient Outcome and Death, D Mort
National confidential enquiry into patient outcome and death, 2008
592008
For Better, for Worse?: A Review of the Care of Patients who Died Within 30 Days of Receiving Systemic Anti-cancer Therapy: a Report by the National Confidential Enquiry Into …
National Confidential Enquiry into Patient Outcome and Death, D Mort
National confidential enquiry into patient outcome and death, 2008
592008
Surgical pathological second opinion in thyroid malignancy: impact on patients' management and prognosis
ZZR Hamady, N Mather, MR Lansdown, L Davidson, KA Maclennan
European Journal of Surgical Oncology (EJSO) 31 (1), 74-77, 2005
472005
The system can't perform the operation now. Try again later.
Articles 1–20